Table 1.
Demographic and clinical characteristics (N = 146).
| Variable | N | % |
|---|---|---|
| Age at diagnosis | ||
| 65–74 | 43 | 29.45 |
| 75–84 | 70 | 47.95 |
| 85+ | 33 | 22.60 |
| Year of diagnosis | ||
| 1989–1994 | 47 | 32.19 |
| 1995–1999 | 66 | 45.21 |
| 2000–2003 | 33 | 22.60 |
| Insurance | ||
| Medicare | 143 | 97.95 |
| Other | 3 | 2.05 |
| Type of residence | ||
| Nursing home | 13 | 8.90 |
| Other | 133 | 91.10 |
| Distance of residence from university clinic | ||
| Within 30 mi | 82 | 56.16 |
| Greater than 30 mi | 62 | 42.47 |
| Unknown | 2 | 1.37 |
| ECOG performance status | ||
| 0 (Fully active) | 117 | 80.14 |
| 1 (Restricted in physically strenuous activity) | 13 | 8.90 |
| 2 (Ambulatory and capable of self-care) | 2 | 1.37 |
| 3 (Capable of only limited self-care) | 8 | 4.48 |
| 4 (Complete disabled) | 6 | 4.11 |
| Charlson score | ||
| 0 | 79 | 54.11 |
| 1 | 37 | 25.34 |
| 2+ | 30 | 20.55 |
| Histology | ||
| Squamous carcinoma | 143 | 97.95 |
| Adenocarcinoma | 3 | 2.05 |
| Disease stage (FIGO) | ||
| Stage I | 45 | 31.25 |
| Stage II | 48 | 33.33 |
| Stage III | 37 | 25.69 |
| Stage IV | 14 | 9.72 |
| Unstaged | 2 | |
| Lymph node involvement | ||
| No histological involvement | 103 | 73.57 |
| Involvement | 37 | 26.43 |
| Unknown | 6 | |
| Adjuvant therapy | ||
| None | 106 | 72.60 |
| Chemotherapy only | 1 | 0.68 |
| Radiation only | 15 | 10.27 |
| Chemotherapy and radiation | 24 | 16.44 |
| Surgeries performed | ||
| Radical vulvectomy only | 26 | 17.81 |
| Local excision only | 6 | 4.11 |
| Unilateral or bilateral inguinal LND | 3 | 2.05 |
| Radical vulvectomy + inguinal LND | 111 | 76.03 |